Ohcanbohtosat - Laurent Beaugerie

Aiddostahte ozu
  1. 1
    Clinical, serological and genetic predictors of inflammatory bowel disease course

    Clinical, serological and genetic predictors of inflammatory bowel disease course Dahkki Laurent Beaugerie

    Almmustuhtton 2012
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Toxic effects of nonsteroidal antiinflammatory drugs on the small bowel, colon, and rectum

    Toxic effects of nonsteroidal antiinflammatory drugs on the small bowel, colon, and rectum Dahkki Gérard Thiéfin, Laurent Beaugerie

    Almmustuhtton 2004
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Balancing Benefit vs Risk of Immunosuppressive Therapy for Individual Patients With Inflammatory Bowel Diseases

    Balancing Benefit vs Risk of Immunosuppressive Therapy for Individual Patients With Inflammatory Bowel Diseases Dahkki Laurent Beaugerie, Julien Kirchgesner

    Almmustuhtton 2018
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Ranitidine, diarrhoea, and lymphocytic colitis.

    Ranitidine, diarrhoea, and lymphocytic colitis. Dahkki Laurent Beaugerie, Natalie Patey, Nicole Brousse

    Almmustuhtton 1995
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Predicting, Preventing, and Managing Treatment-Related Complications in Patients With Inflammatory Bowel Diseases

    Predicting, Preventing, and Managing Treatment-Related Complications in Patients With Inflammatory Bowel Diseases Dahkki Laurent Beaugerie, Jean‐François Rahier, Julien Kirchgesner

    Almmustuhtton 2020
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Predictive factors of outcome of intensive intravenous treatment for attacks of ulcerative colitis

    Predictive factors of outcome of intensive intravenous treatment for attacks of ulcerative colitis Dahkki Carbonnel, Gargouri, Lémann, Laurent Beaugerie, Cattan, Cosnes, Gendre

    Almmustuhtton 2000
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Smoking cessation and the course of Crohn's disease: An intervention study

    Smoking cessation and the course of Crohn's disease: An intervention study Dahkki Jacques Cosnes, Laurent Beaugerie, Franck Carbonnel, Jean–Pierre Gendre

    Almmustuhtton 2001
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Oral contraceptive use and the clinical course of Crohn’s disease: a prospective cohort study

    Oral contraceptive use and the clinical course of Crohn’s disease: a prospective cohort study Dahkki Jacques Cosnes, Franck Carbonnel, Fabrice Carrat, Laurent Beaugerie, J-P Gendre

    Almmustuhtton 1999
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Effects of light smoking consumption on the clinical course of Crohnʼs disease

    Effects of light smoking consumption on the clinical course of Crohnʼs disease Dahkki Philippe Seksik, Isabelle Nion–Larmurier, Harry Sokol, Laurent Beaugerie, Jacques Cosnes

    Almmustuhtton 2008
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    Risk of acute arterial events associated with treatment of inflammatory bowel diseases: nationwide French cohort study

    Risk of acute arterial events associated with treatment of inflammatory bowel diseases: nationwide French cohort study Dahkki Julien Kirchgesner, Nynne Nyboe Andersen, Fabrice Carrat, Tine Jess, Laurent Beaugerie

    Almmustuhtton 2019
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    Malignancies in Inflammatory Bowel Disease

    Malignancies in Inflammatory Bowel Disease Dahkki Thomas Greuter, Stephan R. Vavricka, Alexander König, Laurent Beaugerie, Michael Scharl

    Almmustuhtton 2020
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    Risk of Serious Infections With Vedolizumab Versus Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease

    Risk of Serious Infections With Vedolizumab Versus Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease Dahkki Julien Kirchgesner, Rishi Desai, Laurent Beaugerie, Sebastian Schneeweiß, Seoyoung C. Kim

    Almmustuhtton 2020
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    Predictors of Crohn’s Disease

    Predictors of Crohn’s Disease Dahkki Laurent Beaugerie, Philippe Seksik, Isabelle Nion–Larmurier, Jean–Pierre Gendre, Jacques Cosnes

    Almmustuhtton 2006
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  14. 14
    The effects of aminosalicylates or thiopurines on the risk of colorectal cancer in inflammatory bowel disease

    The effects of aminosalicylates or thiopurines on the risk of colorectal cancer in inflammatory bowel disease Dahkki Fabrice Carrat, Philippe Seksik, Jean–Frédéric Colombel, Laurent Peyrin–Biroulet, Laurent Beaugerie

    Almmustuhtton 2016
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  15. 15
    Incidence, Presentation, and Prognosis of Small Bowel Adenocarcinoma in Patients with Small Bowel Crohnʼs Disease

    Incidence, Presentation, and Prognosis of Small Bowel Adenocarcinoma in Patients with Small Bowel Crohnʼs Disease Dahkki Khaldoun Elriz, Fabrice Carrat, Franck Carbonnel, Lysiane Marthey, Anne‐Marie Bouvier, Laurent Beaugerie

    Almmustuhtton 2013
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  16. 16
    Factors affecting outcomes in Crohn's disease over 15 years

    Factors affecting outcomes in Crohn's disease over 15 years Dahkki Jacques Cosnes, Anne Bourrier, Isabelle Nion–Larmurier, Harry Sokol, Laurent Beaugerie, Philippe Seksik

    Almmustuhtton 2012
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  17. 17
    Anal Neoplasia in Inflammatory Bowel Disease: Classification Proposal, Epidemiology, Carcinogenesis, and Risk Management Perspectives

    Anal Neoplasia in Inflammatory Bowel Disease: Classification Proposal, Epidemiology, Carcinogenesis, and Risk Management Perspectives Dahkki Andrew Wisniewski, Jean–François Fléjou, Laurent Siproudhis, Laurent Abramowitz, Magali Svrcek, Laurent Beaugerie

    Almmustuhtton 2017
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  18. 18
    Increased risk of acute arterial events in young patients and severely active IBD: a nationwide French cohort study

    Increased risk of acute arterial events in young patients and severely active IBD: a nationwide French cohort study Dahkki Julien Kirchgesner, Laurent Beaugerie, Fabrice Carrat, Nynne Nyboe Andersen, Tine Jess, Michaël Schwarzinger

    Almmustuhtton 2017
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  19. 19
    Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis

    Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis Dahkki Harry Sokol, Jacques Cosnes, Olivier Chazouillères, Laurent Beaugerie, Emmanuel Tiret, Raoul Poupon, Philippe Seksik

    Almmustuhtton 2008
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  20. 20
    Incidence of benign upper respiratory tract infections, HSV and HPV cutaneous infections in inflammatory bowel disease patients treated with azathioprine

    Incidence of benign upper respiratory tract infections, HSV and HPV cutaneous infections in inflammatory bowel disease patients treated with azathioprine Dahkki Philippe Seksik, Jacques Cosnes, Harry Sokol, Isabelle Nion–Larmurier, J P Gendre, Laurent Beaugerie

    Almmustuhtton 2009
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: